EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Magnetically Integrated Tumor–Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing

Vikram Surendran, Simrit Safarulla, Christian Griffith, Reem Ali, Ankit Madan, William Polacheck, Arvind Chandrasekaran iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c01766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Vikram Surendran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioinspired Microengineering (BIOME) Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina A&T State University, Greensb…. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association-American Stroke Association, NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor-vascular interface is a critical component of the tumor microenvironment that regulates all of the dynamic interactions between a growing tumor and the endothelial lining of the surrounding vasculature. In this paper, we report the design and development of a custom-engineered tumor-vascular interface system for investigating the early stage tumor-mediated pro-angiogenic dysfunctional behavior of the endothelium. Using representative endothelial cells and triple negative breast cancer cell lines, we established a biomimetic interface between a three-dimensional tumor tissue across a mature, functional endothelial barrier using a magnetically hybrid-integrated tumor-vascular interface system, wherein vasculature-like features containing a monolayer of endothelial cell culture on porous microfluidic channel surfaces were magnetically attached to tumor spheroids generated on a composite polymer-hydrogel microwell plate and embedded in a collagen matrix. Tumor-mediated endothelial microdynamics were characterized by their hallmark behavior such as loss of endothelial adherens junctions, increased cell density, proliferation, and changes in cell spreading and corroborated with endothelial YAP/TAZ nuclear translocation. We further confirm the feasibility of drug-mediated reversal of this pro-angiogenic endothelial organization through two different signaling mechanisms, namely, inhibition of the vascular endothelial growth factor pathway and the Notch signaling pathway, thereby demonstrating the utility of the tumor-vascular interface platform for rapid, early stage prediction of antiangiogenic drug efficacy. Overall, our work emphasizes the importance of our strategic engineering approach for identifying some unique, physiologically relevant aspects of the tumor-vascular interface, which are otherwise difficult to implement using standard in vitro approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lab-On-A-Chip DevicesHumansNeovascularization, PathologicCell Line, TumorHuman Umbilical Vein Endothelial CellsEndothelial CellsTumor Microenvironment

Stichwörter der Autor:innen

VEGF inhibitorangiogenesisendothelial YAP/TAZhybrid integrationmagnetic attachmentnotch signalingtumor endotheliumtumor–vascular interface

Autor:innen und Institutionen

  • Bioinspired Microengineering (BIOME) Laboratory, Department of Chemical, Biological and Bio Engineering, North Carolina A&T State University, Greensboro, North Carolina 27265, United States.
  • Joint Department of Biomedical Engineering, UNC Chapel Hill─NC State University, Chapel Hill, North Carolina 27599, United States.
  • MedStar Southern Maryland Hospital Center, MedStar Georgetown Cancer Institute, Clinton, Maryland 20735, United States.

ORCID-Profile: Arvind Chandrasekaran

Förderung

  • American Heart Association-American Stroke Association
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • American Heart Association
  • Defense Human Resources Activity
  • North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Surendran, V., Safarulla, S., Griffith, C., Ali, R., Madan, A., Polacheck, W., & Chandrasekaran, A. (2024). Magnetically Integrated Tumor–Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c01766

Vancouver

Surendran V, Safarulla S, Griffith C, Ali R, Madan A, Polacheck W, et al. Magnetically Integrated Tumor–Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c01766

BibTeX
@article{Surendran2024,
  author = {Surendran, Vikram and Safarulla, Simrit and Griffith, Christian and Ali, Reem and Madan, Ankit and Polacheck, William and Chandrasekaran, Arvind},
  title = {Magnetically Integrated Tumor–Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c01766}
}
Kostenlos starten →